Skip to search formSkip to main contentSkip to account menu
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled,…
View on Elsevier
Ovarian hormones and cortical excitability. An rTMS study in humans
View on Elsevier
Attention influences the excitability of cortical motor areas in healthy humans
TLDR
In healthy subjects attentional processes influence the size of the MEP facilitation elicited by high-frequency rTMS and do so through premotor-to-motor connections.
View on Springer
Dysphagia in amyotrophic lateral sclerosis: prevalence and clinical findings
TLDR
To characterize swallowing deficits in amyotrophic lateral sclerosis (ALS) and investigate the delay in dysphagia onset, correlations between dysphagIA severity and patients' functional status are estimated and the symptom(s) most likely to predict dysphagian symptoms are identified.
View on Wiley
Effect of corpus callosum damage on ipsilateral motor activation in patients with multiple sclerosis: A functional and anatomical study
TLDR
The data suggest that functional changes in iM1 in patients with MS during a motor task partially represents a consequence of loss of transcallosal inhibitory fibers.
View on Wiley
Intracortical excitability in patients with relapsing–remitting and secondary progressive multiple sclerosis
TLDR
Investigation of possible correlations between variables measuring primary motor cortex excitability detected by single and paired-pulse transcranial magnetic stimulation and the severity of clinical manifestations in patients with multiple sclerosis found that intracortical excitability as measured with TMS differs according to the clinical course of MS.
View on Springer
Altered response to rTMS in patients with Alzheimer's disease
View on Elsevier
Acute and chronic effects of ethanol on cortical excitability
View on Elsevier
Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine
TLDR
3,4-DAP may modulate brain motor activity in patients with MS, probably by enhancing excitatory synaptic transmission.
View on Wolters Kluwer
Cannabinoid‐induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis
View on Wiley
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License